Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.
Saavedra
Juan M
JM
Section on Pharmacology, Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, 10 Center Drive, Building 10, Room 2D-57, Bethesda, MD 20892, USA. Saavedrj@mail.nih.gov
Sánchez-Lemus
Enrique
E
Benicky
Julius
J
D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology* / Q000627:therapeutic use*; D000818:Animals; D001007:Anxiety / Q000150:complications / Q000188:drug therapy*; D002545:Brain Ischemia / Q000150:complications / Q000188:drug therapy*; D004660:Encephalitis / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008954:Models, Biological; D044140:Receptor, Angiotensin, Type 1 / Q000378:metabolism / Q000502:physiology; D013315:Stress, Psychological / Q000150:complications / Q000188:drug therapy*
D047228:Angiotensin II Type 1 Receptor Blockers; D044140:Receptor, Angiotensin, Type 1